Rethinking antibody discovery in the age of automation
James Atwood, COO of Opentrons, shares how accessible lab automation…
James Atwood, COO of Opentrons, shares how accessible lab automation is helping research teams tackle tighter budgets, faster timelines and complex discovery workflows.